Speakers

Speakers

Dr Werngard Czechtizky, Head Medicinal Chemistry, Respiratory and Immunolo, AstraZeneca

photo of Dr Werngard Czechtizky

Werngard Czechtizky obtained her PhD at ETH Zürich. After a postdoctoral stay at Harvard University, she worked on GPCR lead generation in a global Chemical Biology platform at Aventis. At Sanofi, from 2005, she moved into a parallel synthesis team working in the fields of CNS and CV diseases. In 2010, she became leader of a Medicinal Chemistry section working on Diabetes programs. In 2014, she was appointed Head of Chemistry at Sanofi R&D Germany, with therapeutic focus on Diabetes, pain and inflammatory indications. Since 2017, she is Head of Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, at AstraZeneca in Sweden.

Presentation Title: Bridging the Discovery/Early Development Interface - New chemistries, AI and Automation for Efficient Route Finding, External Sourcing and Sustainability

View company profile